デ・ウエスタン・セラピテクス研究所（4576） – [Delayed]Summary of Consolidated Financial Results for the Three Months Ended March 31, 2022(Based on Japanese GAAP)

Translation Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any discrepancy between this translated document and the original Japanese document, the latter shall prevail. Summary of Consolidated Financial Results for the Three Months Ended March 31, 2022 (Based on Japanese GAAP) D.Western Therapeutics Institute, Inc. Company name: Stock exchange listing: Tokyo Stock code: Representative: 4576 President and CEO URL https://www.dwti.co.jp Yuichi Hidaka Inquiries: Director and General Administration Division Manager Tetsuya Kawakami TEL 052-218-8785 May 12, 2022Scheduled date to file Quarterly Securities Report: Scheduled date to commence dividend payments: May 12, 2022 – Preparation of supplementary material on quarterly financial results: No Holding of quarterly financial results meeting: No 1. Consolidated financial results for the three months ended March 31, 2022 (from January 1, 2022 to March 31, 2022) (1) Consolidated operating results (cumulative) Net sales Operating profit Percentages indicate year-on-year changesProfit attributable to owners of parent Ordinary profit Three months ended March 31, 2022 Three months ended March 31, 2021 Millions of yen 109 89 % Millions of yen (37) (50) 22.3 20.2 % Millions of yen (26)– (40)– % Millions of yen (21) – (41) – % – – (Amounts less than one million yen are rounded down)Three months ended March 31, 2022 Three months ended March 31, 2021 (2) Consolidated financial position As of March 31, 2022 As of December 31, 2021 2. Cash dividends Earnings per share Diluted earnings per share Yen (0.74)(1.41)Total assets Net assets Equity ratio Millions of yen 2,387 2,462 Millions of yen 2,008 2,035 % 83.0 81.4 1st quarter-end 2nd quarter-end 3rd quarter-end Fiscal year-end Total Annual dividends per share Year ended December 31, 2021 Year ending December 31, 2022 Year ending December 31, 2022 (Forecast) Yen – – Yen 0.00 0.00 Yen 0.00 0.00 Yen 0.00 0.00 3. Forecast of consolidated financial results for the year ending December 31, 2022 (from January 1, 2022 to December 31, 2022) Net sales Operating profit Ordinary profit Percentages indicate year-on-year changesProfit attributable to owners of parent Earnings per share Full year Millions of yen 370 % Millions of yen (690)(10.7)% Millions of yen (700)– % Millions of yen (670) – % – Yen (22.82)Yen – – Yen – – 14. Notes (1) Changes in significant subsidiaries during the three months ended March 31, 2022 (changes in specified subsidiaries resulting in the change in scope of consolidation): (2) Application of special accounting methods for preparing quarterly consolidated financial statements: No (3) Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements Changes in accounting policies due to revisions to accounting standards and other regulations: Changes in accounting policies due to other reasons: Changes in accounting estimates: Restatement of prior period financial statements: (4) Number of issued shares (common shares) Total number of issued shares at the end of the period (including treasury shares) No Yes No No No As of March 31, 2022 29,358,600 shares As of December 31, 2021 29,358,600 shares Number of treasury shares at the end of the period As of March 31, 2022 100 shares As of December 31, 2021 100 shares Average number of shares during the period (cumulative from the beginning of the fiscal year) Three months ended March 31, 2022 29,358,500 shares Three months ended March 31, 2021 29,283,345 shares 2Quarterly consolidated financial statements Consolidated balance sheets As of December 31, 2021 As of March 31, 2022 (Thousands of yen) 2,462,860 2,387,687 1,933,743 101,674 88,399 38,365 2,162,183 4,567 164,571 2,047 166,619 129,489 300,676 129,524 41,759 9,889 12,072 193,245 210,476 24,000 234,476 427,721 573,159 2,631,398 (1,200,276) 2,004,281 – – 2,692 28,164 2,035,138 2,462,860 1,768,982 170,046 88,393 68,137 2,095,559 6,600 154,285 1,768 156,054 129,473 292,128 134,286 28,975 4,504 12,144 179,910 175,714 24,000 199,714 379,624 573,159 2,631,398 (1,222,137) 1,982,419 (569) (569) 2,692 23,520 2,008,062 2,387,687 Assets Current assets Cash and deposits Accounts receivable – trade Supplies Other Total current assets Non-current assets Property, plant and equipment Intangible assets Contract-related intangible assets Other Total intangible assets Investments and other assets Total non-current assets Total assets Liabilities Current liabilities Current portion of long-term borrowings Accounts payable – other Income taxes payable Other Total current liabilities Non-current liabilities Long-term borrowings Other Total non-current liabilities Total liabilities Net assets Shareholders’ equity Share capital Capital surplus Retained earnings Total shareholders’ equity Accumulated other comprehensive income Valuation difference on available-for-sale securities Total accumulated other comprehensive income Share acquisition rights Non-controlling interests Total net assets Total liabilities and net assets 3Consolidated statements of income (cumulative) and consolidated statements of comprehensive income (cumulative) Consolidated statements of income (cumulative) (Thousands of yen) Three months ended Three months ended March 31, 2021 March 31, 2022 Net sales Cost of sales Gross profit Other Selling, general and administrative expenses Research and development expenses Total selling, general and administrative expenses Operating loss Non-operating income Interest income Foreign exchange gains Other Total non-operating income Non-operating expenses Interest expenses Other Total non-operating expenses Ordinary loss Loss before income taxes Income taxes – current Total income taxes Loss Loss attributable to non-controlling interests Loss attributable to owners of parent 89,688 3,916 85,771 65,574 71,001 136,576 (50,805) 9 11,049 132 11,190 1,216 113 1,330 (40,944) (40,944) 398 398 – (41,343) (41,343) 109,717 7,001 102,715 75,971 64,735 140,706 (37,991) 13 11,781 1,000 12,794 886 24 910 398 398 (26,107) (26,107) (26,506) (4,644) (21,861) 4Consolidated statements of comprehensive income (cumulative) Loss Other comprehensive income Valuation difference on available-for-sale securities Total other comprehensive income Comprehensive income Comprehensive income attributable to Comprehensive income attributable to owners of parent Comprehensive income attributable to non-controlling interests (Thousands of yen) Three months ended Three months ended March 31, 2021 March 31, 2022 (41,343) – – – (41,343) (41,343) (26,506) (569) (569) (27,075) (22,431) (4,644) 5